Esbriet (pirfenidone)

pCPA File Number: 20888

Negotiation Status:

Concluded with an LOI

Indication(s):

Pulmonary fibrosis (idiopathic, mild to moderate)

Sponsor/Manufacturer:

Hoffmann-La Roche

CADTH Project Number:

SR0393

pCPA Engagement Letter Issued:

2015-04-30

Negotiation Process Concluded:

2016-09-11